Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Treatment With EGb 761(r) on Blood Markers of Inflammation and Oxidative Stress in a Cohort of Patients With Mild Cognitive Impairment

NCT05594355 is registered in ClinicalTrials.gov with Fundació ACE Institut Català de Neurociències Aplicades as lead sponsor.

NCT NCT05594355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05594355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Treatment With EGb 761(r) on Blood Markers of Inflammation and Oxidative Stress in a Cohort of Patients With Mild Cognitive Impairment
Lead sponsor
Fundació ACE Institut Català de Neurociències Aplicades
Phase
Phase 4
Overall status
Unknown status
Start date
April 16, 2021
Completion date
December 31, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment (mci)